4//SEC Filing
Rubin Jami 4
Accession 0000950170-24-099296
CIK 0001782303other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 7:03 PM ET
Size
17.0 KB
Accession
0000950170-24-099296
Insider Transaction Report
Form 4
Rubin Jami
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option
2024-08-19−196,666→ 0 totalExercise: $4.10Exp: 2033-07-25→ Common Stock (196,666 underlying) - Award
Stock Option
2024-08-19+196,666→ 196,666 totalExercise: $3.56Exp: 2033-07-25→ Common Stock (196,666 underlying) - Disposition to Issuer
Stock Option
2024-08-19−51,420→ 0 totalExercise: $8.19Exp: 2034-02-14→ Common Stock (51,420 underlying) - Disposition to Issuer
Stock Option
2024-08-19−32,468→ 0 totalExercise: $16.00Exp: 2034-03-26→ Common Stock (32,468 underlying) - Award
Stock Option
2024-08-19+51,420→ 51,420 totalExercise: $3.56Exp: 2034-02-14→ Common Stock (51,420 underlying) - Award
Stock Option
2024-08-19+32,468→ 32,468 totalExercise: $3.56Exp: 2034-03-26→ Common Stock (32,468 underlying)
Footnotes (5)
- [F1]The stock option vested as to 25% of the underlying shares in connection with the consummation of the Issuer's initial public offering, and vests as to the remaining underlying shares in 36 substantially equal monthly installments beginning on August 31, 2024.
- [F2]On August 19, 2024, the Issuer repriced the option. Except as further described in footnote 5, all other terms of the option remain unchanged.
- [F3]The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024.
- [F4]The stock option vests in 48 substantially equal monthly `installments beginning on April 27, 2024.
- [F5]The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "premium end date" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a "qualifying termination" (as defined below). The "premium end date" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A "qualifying termination" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability.
Documents
Issuer
Boundless Bio, Inc.
CIK 0001782303
Entity typeother
Related Parties
1- filerCIK 0001816484
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 7:03 PM ET
- Size
- 17.0 KB